Not known Facts About Psychoactive cannabinoids
NIDA supports epidemiology, coverage analysis and community wellness outcomes analysis related to cannabis use, including the Checking the Future survey plus a medicinal cannabis use registry.In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they intend to reclassify cannabis being a Routine III drug. This rescheduling will recogniz